CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-Guérin
Jeongwan Yoo, Yeon Joo Kim, Bum Sik Tae, Jae Young Park
Korean J Urol Oncol. 2020;18(2):73-77.   Published online 2020 August 27    DOI: https://doi.org/10.22465/kjuo.2020.18.2.73

Excel Download

Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-Guérin
The Korean Journal of Urological Oncology. 2020;18(2):73-77   Crossref logo
Link1 Link2 Link3

Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer
Cancer. 2008;113(4):710-716   Crossref logo
Link1 Link2

Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
Urology. 2019;124:120-126   Crossref logo
Link1 Link2

Therapeutic Options in High-risk Non–muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guérin
European Urology. 2015;67(3):359-360   Crossref logo
Link1 Link2

Editorial comment on “Maintenance bacillus Calmette-Guérin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials”
Urological Science. 2015;26(2):101-102   Crossref logo
Link1 Link2

Re: The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
European Urology. 2015;67(4):815   Crossref logo
Link1 Link2

The Challenge of Bacillus Calmette-Guérin Failure in Nonmuscle Invasive Bladder Cancer—What is the Next Step in Management?
Journal of Urology. 2013;190(3):832-833   Crossref logo
Link1 Link2

Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer
BJU International. 2009;103(6):726-729   Crossref logo
Link1

The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
Urologia Internationalis. 2015;96(1):46-50   Crossref logo
Link1 Link2

BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer
Surgical Oncology. 2002;11(1-2):77-83   Crossref logo
Link1 Link2